4D Molecular Therapeutics Inc.
4DMT Highlights Robust and Durable Clinical Activity for 4D 150 and[...]
09/25/2021 | News release | Distributed by Public on 09/25/2021 09:45
Please select the service you want to use:
Smartlinks | Debbie Stabenow | United States Senate | News | Social and Non-Profit | Politics and Policy | Government | National Government | International Policy | Public Officials
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact